Iomai - Worst Pharma Stocks of 2007
Company: Iomai
Starting stock price: $4.85
Ending stock price: $1.03
Percent Change: -78.76%
Details: Iomai reported in May that it's needle-free flu vaccine demonstrated less of an immune response than an injection, sending its stock down 35%. The company is also developing a patch for traveler's diarrhea that has delivered promising results, and is working on two immunostimulant patches for pandemic flu.
More News:
Iomai vax patch guards against traveler's diarrhea. Report
Vaccine-maker Iomai files $83M IPO. Report
Be the first to comment
More stories about Iomai
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets